While whole-plant produced biopharmaceuticals account for a significant portion of the preclinical and clinical pipeline, plant cell suspension culture, which integrates the merits of whole-plant systems with those of microbial fermentation, is emerging as a more compliant alternative "factory".
Although STM resistance mechanisms have been proposed in many clinical bacteria, plant and animal pathogens (De Leon Door et al. 2013; Sundin et al. 1995; Sundin 2002; Um et al. 2016), the resistance spectra in wastewater communities are still poorly understood.
Weekly administration of cisplatin has extensively been studied at our institution in a range of prospective clinical trials (Planting et al, 1993, 1994, 1995a, 1995b, 1997a, 1997b; van der Burg et al, 1998; van den Bent et al, 1999, 2002).
The majority of patients participated in phase I/II clinical trials (Planting et al, 1993, 1994, 1995a, 1995b, 1997a, 1997b; van der Burg et al, 1998, 2002; van den Bent et al, 1999).
The demand of natural product is increasing proportionally due to medico clinical applications of plant products.
The ability to express high levels of foreign protein, particularly those of clinical interest, makes plant plastids an attractive target for biotechnology.
The son of an 84-year-old male discovered a newspaper report stating clinical success with plant extracts in Alzheimer's disease.
Intense research in this area has lead to multiple ongoing clinical trials involving plant derivatives while a few have already been approved for human use [ 16- 18].
Most new clinical applications of plant secondary metabolites and their derivatives over the last half century have been applied towards combating cancer [ 32].
Drug discovery from medicinal plants has played an especially important role in the treatment of cancer and, indeed, over the last half century, most new clinical applications of plant secondary metabolites and their derivatives have been applied towards combating cancer [ 32].
